Abstract
The authors failed to explicitly recognize the major experimental and conceptual input of Dr. C. Norman Coleman and collaborators to the development of the therapeutic paradigm discussed in this review. The authors apologize to Dr. Coleman, his colleagues and the entire field of radiation oncology and have rectified the final section of the introduction to reflect this contribution. This omission has been corrected in both the HTML and PDF versions of this manuscript.
| Original language | English |
|---|---|
| Pages (from-to) | 281 |
| Number of pages | 1 |
| Journal | Nature Reviews Clinical Oncology |
| Volume | 19 |
| Issue number | 4 |
| DOIs |
|
| State | Published - Apr 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver